logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11331390 B1

PDFFull Text
Date of Patent:
May. 17, 2022

Filed:

Apr. 21, 2017

Ophthalmic composition

Applicant:

Rohto Pharmaceutical Co., Ltd., Osaka, JP;

Inventor:

Yasuko Matsumura, Osaka, JP;

Assignee:

ROHTO PHARMACEUTICAL CO., LTD., Osaka, JP;

Attorney:

Morgan, Lewis & Bockius LLP

Primary Examiner:

Savitha M Rao

Assistant Examiner:

Andrew P Lee

Int. Cl.
CPC ...
A61K 47/26 (2006.01); A61K 9/00 (2006.01); A61K 31/045 (2006.01); A61K 31/14 (2006.01); A61K 31/355 (2006.01); A61K 47/44 (2017.01); A61K 47/10 (2017.01); C08J 5/00 (2006.01); A61K 47/18 (2017.01); A61K 47/12 (2006.01); A61K 47/02 (2006.01); A61K 47/22 (2006.01);
U.S. Cl.
CPC ...
A61K 47/26 (2013.01); A61K 9/0048 (2013.01); A61K 31/045 (2013.01); A61K 31/14 (2013.01); A61K 31/355 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/44 (2013.01); C08J 5/00 (2013.01); A61K 47/186 (2013.01); A61K 47/22 (2013.01); C08J 2365/00 (2013.01);
Abstract

The first aspect of the present invention relates to an ophthalmic composition comprising (A) one or more kinds selected from the group consisting of terpenoid, a tocopherol, and a benzyl ammonium compound and a salt thereof, wherein the ophthalmic composition is contained in a container in which a portion or the whole of a part coming into contact with the ophthalmic composition is formed from a resin containing a cyclic olefin. The second aspect of the present invention relates to an ophthalmic composition comprising (A2) a surface active component and (B2) a buffer, wherein the ophthalmic composition is contained in a container in which a portion or the whole of a part coming into contact with the ophthalmic composition is formed from a resin containing a cyclic olefin.

Find Patent Forward Citations

Loading…